Transforming health and human capacity
Total raised: $17M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.03.2025 | Seed | $17M | - |
Mentions in press and media 6
| Date | Title | Description |
| 03.03.2025 | Subsense: $17 Million (Seed) Secured For Non-Surgical Brain-Computer Interface | Subsense, a neurotechnology company developing the first non-surgical, nanoparticle-based Brain-Computer Interface (BCI), emerged from stealth to formally reveal its efforts in the emerging field of non-invasive brain connectivity. Founded ... |
| 25.02.2025 | Subsense: $17 Million (Seed) Secured For A Non-Surgical Brain-Computer Interface | Subsense, a neurotechnology company developing the first non-surgical, nanoparticle-based Brain-Computer Interface (BCI), announced it emerged from stealth to formally reveal its efforts in the emerging field of non-invasive brain connectiv... |
| 19.02.2025 | Subsense: Bridging Minds and Machines with Nanoparticles | In the world of neurotechnology, Subsense, Inc. is making waves. This Palo Alto-based company has emerged from stealth mode, armed with $17 million in seed funding. The backing comes from Golden Falcon Capital, a venture firm with an eye fo... |
| 18.02.2025 | Subsense Emerges from Stealth with $17M to Develop Non-Surgical Brain-Computer Interface | What You Should Know: – Subsense, Inc., a pioneering neurotechnology company announced its official launch and the closing of a $17 million seed funding round led by Golden Falcon Capital. – The company is developing a groundbreaking non-su... |
| 18.02.2025 | Subsense Raises $17M in Seed Funding | Subsense, a Palo Alto, CA-based neurotechnology company developing a non-surgical, nanoparticle-based Brain-Computer Interface (BCI), raised $17M in Seed funding. The round was led by Golden Falcon Capital. The company intends to use the fu... |
| - | Subsense | “Transforming health and human capacity” |